Anti-proliferative and anti-migration effects of Polish propolis combined with  L. on glioblastoma multiforme cell line U87MG by unknown
RESEARCH ARTICLE Open Access
Anti-proliferative and anti-migration effects
of Polish propolis combined with
Hypericum perforatum L. on glioblastoma
multiforme cell line U87MG
Maria H. Borawska*, Sylwia K. Naliwajko, Justyna Moskwa, Renata Markiewicz-Żukowska, Anna Puścion-Jakubik
and Jolanta Soroczyńska
Abstract
Background: Propolis and Hypericum perforatum L. are natural products which contain many active compounds
and have numerous beneficial effects, including an antitumor effect. Gliobmastoma multiforme (GBM) is a common
primary brain tumor with poor prognosis and limited treatment options. In this study, the effect of propolis (EEP)
combined with H. perforatum L. (HPE) on glioblastoma cell line U87MG was investigated for the first time.
Methods: Anti-proliferative activity of EEP, HPE and their combination (EEP + HPE) was determined by a cytotoxicity
test, DNA binding by [3H]-thymidine incorporation and cell migration assay. Anti-metastatic properties in U87MG
treated with EEP, HPE and EEP + HPE were estimated on cells migration test (scratch assay) and metalloproteinases
(MMP2 and MMP9) secretion (gelatin zymography).
Results: Combination of HPE and EEP extracts was found to have a time- and dose-dependent inhibitory effect on
the viability of U87MG cells. This effect was significantly higher (p < 0.05) when compared to these two extracts
applied separately, which was confirmed by the significant reduction of DNA synthesis and significantly higher
mitochondrial membrane permeabilization. A significant decreasing in migration cells and in pro-MMP9 and
pro-MMP2 secretion in U87MG cells were demonstrated after exposure to combination of EEP (30 μg/ml) with HPE
(6.25 μg/ml).
Conclusions: In this study, the combination of ethanolic extract from propolis and ethanolic extract of fresh-cut H.
perforatum L. was proved the ability to reduce invasiveness of glioma cells through the inhibition of MMP2 and
MMP9 secretion and suppression of cell migration. It has a more potent anti-proliferative effect on U87MG glioma
cell line compared to using propolis and H. perforatum L. separately. Further studies are required to verify whether
the examined extracts can activate apoptotic pathways.
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Background
Glioblastoma multiforme (GBM) is the most malignant
human brain tumor, with median survival of one year.
The malignant glioma cells are able to extensively invade
surrounding brain parenchyma. The matrix metallopro-
teinases (MMPs) contribute to cancer cell invasion and
metastasis through the cell-surface extracellular matrix
(ECM) degradation [1]. Common resistance to chemo-
therapy and lack of effective therapy have encouraged
search for new forms of treatment. It is common that
oncological patients often use supplements with medi-
cinal plant or bee products (such as propolis) to support
the therapy [2, 3]. The use of various combinations of
plant extracts may improve the effectiveness of treat-
ment but, on the other hand, it can be dangerous be-
cause of their possible interactions [4].
Hypericum perforatum L. (commonly known as St.
John’s wort) is best known for its use in treatment of de-
pressive disorders, but its mechanism of action is un-
clear. Most researchers confirm that its effect is related
to the return uptake of serotonin at the neural synapses
and inhibition of monoamine oxidase (MAO). Currently,
many phyto- and nutraceuticals, tinctures, teas, juices
with St. John's Wort are available on the market [5]. St.
John’s wort extract is also used in treatment of wound
healing, bacterial and viral infections [6, 7]. The activity
of H. perforatum L. is associated with its active com-
pounds, like naphthodianthrone (hypericin, isohypericin),
flavonoids (kaempherol, quercetin, rutin), prenylated
phloroglucinols (hyperforin, adhyperforin), tannins, aro-
matic acids (caffeic, p-coumaric, chlorogenic) [8, 9]. Many
studies have already confirmed the antitumor effect of Hy-
pericum perforatum L. and hypericin (one of the major ac-
tive components) [10–12]. Noell et al. [13] indicated the
selective accumulation of hypericin in the tumor implant-
ation (C6 glioma) in rats. Moreover, hypericin was shown
to be a promising anticancer compound in the photo-
dynamic therapy [14].
Propolis is a natural bee product characterized by the
rich chemical composition, where the most active com-
pounds are flavonoids (e.g. chrysin, apigenin, pinocembrin,
pinobanksin, kaempferol), aromatic acids (e.g. p-coumaric,
ferulic), esters (caffeic acid phenethyl ester – CAPE)
[15, 16]. The antibacterial, antifungal, antiviral and anti-
inflammatory activity were proved by many researchers
[17–19]. The recent in vitro studies have also confirmed
a wide anti-cancer effect on various cell lines such as
human lung cancer (A549) [20], human prostate cancer
(PC3) [21], human myeloid leukemia (U937) [22]. In
our previous studies, we examined the influence of
propolis extract and other bee products on human glio-
blastoma cells (U87MG) [23, 24]. Propolis presented the
highest cytotoxic properties compared to other tested
bee products and reduced the activity of NF-кB in the
glioblastoma cell line (U87MG). Moreover, the ethanolic
extract of propolis synergistically enhanced the activity
of temozolomide against the proliferation of U87MG
cells.
The aim of our study was to examine the effect of H.




Minimal essential medium eagle (MEM) with l-glutamine
(292 mg/L), fetal bovine serum (FBS), trypsin-EDTA, peni-
cillin, streptomycin were purchased from PAA Laborator-
ies GmbH (Pasching, Austria); calcium-free phosphate
buffered saline (PBS) was from Biomed (Lublin, Poland),
methylthiazolyl diphenyl-tetrazolium bromide (MTT), di-
methyl sulfoxide (DMSO) were obtained from Sigma-
Aldrich (St. Louis, MO, USA). Acrylamide/bis-acrylamide
solution, ammonium persulfate, bovine serum albumin,
brilliant blue R, bromophenol blue, calcium chloride,
glycine, glycerol, sodium dodecyl sulfate (SDS), N,N,N’N’-
tetramethylethylenediamine (TEMED), trichloroacetic
acid, triton X-100, trizma base were obtained from Sigma-
Aldrich (St. Louis, MO, USA). Prestained protein standard
from BioRad. The scintillation cocktail was purchased
from PerkinElmer (Boston, MA) and methyl-3H thymidine
from MP Biomedicals, Inc. (Irvine, USA). Solutions: 7
(200 μg/ml 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetra-ethylbenzimi-
dazolocarbocyanine iodide (JC-1) and solution 8 (1 μg/ml
DAPI in PBS) to NucleoCounter assays were obtained
from ChemoMetec, Denmark. All other chemicals were of
ultrapure grade and obtained from Sigma-Aldrich (St.
Louis, MO, USA).
Materials and extraction
Bee-propolis and the plant material H. perforatum L.
were collected in the region of Podlasie, north-eastern
Poland in 2014 (propolis) and 2015 (H. perforatum L.).
Voucher specimens were deposited in the Department
of Bromatology in the Medical University of Bialystok
(ZB/PP/2014/04; ZB/PL/2015/02).
Propolis was crushed and 20 g were extracted in a
shaker with 80 g of 95 % ethanol for 6 h in a darkened
place. The extract was filtered and concentrated to dry-
ness in a rotary evaporator under reduced pressure and
controlled temperature. To obtain a dry extract the sam-
ple was lyophilized. The dry ethanolic extract of propolis
(EEP) was protected from light and kept frozen at −80 °C.
The yield of the prepared extract (% w/w), in terms of the
starting material, was 39.5.
Fresh aerial parts of H. perforatum L. was cut and 80 g
were extracted using a maceration technique with 500 g
ethanol 95 % for 6 h at room temperature in darkness.
Extraction was repeated two times over 48 h. The yield
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(% w/w) was 9.4. The mixture was filtered, concentrated
and lyophilized. The obtained ethanolic extract of fresh-
cut H. perforatum L. (HPE) was kept in −80 °C for future
assays.
Cell culture
The studies were performed on human glioblastoma
U87MG cell line obtained from the American Type Cul-
ture Collection (ATCC, Rockville, MD, USA). The study
did not require the approval of the ethics committee.
The cells were cultured in a humidified incubator at 37 °C
and 5 % CO2 atmosphere in growth medium - MEM
supplemented with 10 % FBS; 50 U/mL penicillin and
50 mg/mL streptomycin.
Morphological analysis under light microscopy
For the morphological analysis, a U87MG cell line was
seeded in 100-mm dishes at 2.2 × 106 cells/ml. The cells
were treated with HPE (6.25 μg/ml), EEP (30 μg/ml) and
combination HPE with EEP for 24 h. Then the morpho-
logical changes were examined based on the visual assess-
ment and recorded under a light microscope (Olympus
CKX41).
Cytotoxicity assay
Lyophilized HPE and EEP were dissolved separately in
DMSO and growth medium at 1000 μg/ml concentra-
tion as a stock solution. Further dilutions were made in
culture medium. HPE was used at different concentra-
tions ranging from 1.56 to 100 μg/ml and EEP at 30 μg/
ml. The concentration of EEP (30 μg/ml) was chosen,
based on the previous data [23]. The final concentration
of DMSO was less than 0.1 %.
U87MG cells were seeded at a density of 2 × 104 cells
per well of a 96-well plate and grown for 24 h. Cells
were incubated with prepared different concentrations
of HPE and EEP for 24, 48 and 72 h. The control in-
cluded 0.1 % DMSO. A 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide (MTT) viability assay was
performed as previously described [24]. The absorbance
at 570 nm proportional to the number of living cells was
measured on a Multimode Plate Reader Victor X3
(PerkinElmer, Singapore). The data were expressed as a
percentage of control. The cells from passage 8 to
11were used. The experiment was performed in tripli-
cate and repeated at least three times independently.
[3H]-thymidine incorporation
U87MG cells were seeded in 24-well plates at 1.5 × 105
per well and grown for 24 h. Next, U87MG cells were
treated with HPE (6.25 μg/ml), EEP (30 μg/ml), their
combination and control (0.1 % DMSO). After 44- h in-
cubation 0.5 μCi of [3H]-thymidine was added to each
well. Cells were incubated for 4 h. Next the medium was
removed and cells were washed twice with cold (4 °C)
0.05 M Tris-HCl and 5 % trichloroacetic acid. At the
end cells were collected and placed into the scintillation
cocktail. The level of [3H]-thymidine incorporated in the
newly synthesized DNA strand in relation to cells prolif-
erating during the S phase of the cell cycle was assessed
by a scintillation counter. The cells from passage 11 to
13 were used.
Mitochondrial potential assay
Mitochondrial membrane permeabilization was ana-
lyzed, applying the mitochondrial potential JC-1 stain
assay with the NucleoCounter NC-3000 instrument and
following instructions from the producer. Staining solu-
tions used for the assay were the following: Solution 7
containing 200 μg/ml of 5,5’,6,6’-tetrachloro-1,1’,3,3’-
tetra-ethylbenzimidazolocarbocyanine iodide (JC-1) and
Solution 8 containing 1 μg/ml DAPI in PBS.
U87MG cells were seeded in 6-well plates at 0.7 × 106
per well and grown for 24 h. Next, U87MG cells were
treated with HPE (6.25 μg/ml), EEP (30 μg/ml), EEP
with HPE and control (0.1 % DMSO). After 24-h incuba-
tion the mitochondrial potential was measured accord-
ing to the NucleoCounter NC-3000 protocol. The cells
from passage 14 to 16 were used.
Migration assay (Scratch assay)
U87MG cells were cultured until more than 70 % of
confluent growth for each well of 6-well plates, at 37 °C
in a humidified atmosphere of 5 % CO2. Seeded cells in
well plates were scratched with a 20–300 μl micropipette
tip to the same length and width. U87MG cells were
treated with HPE (6.25 μg/ml), EEP (30 μg/ml), EEP
with HPE and control (0.1 % DMSO) and then incu-
bated for 48 h. The images of each treatment group were
captured at 100× magnification, using an Olympus CKX
41 microscope and KcJunior programme at each time
point (0, 12, 48 h).
Gelatin zymography
The gelatin zymography was used to assess the extent of
pro-MMP2 and pro-MMP9 (as a precursors of MMPs:
MMP2 and MMP9) activity [25]. The serum-free media
with the study substances from subconfluent cells
(U87MG) grown for 24 h in 100-mm plates were col-
lected and concentrated 35-fold by ultrafiltration using
3 kDa concentrators and mixed with Laemmli sample
buffer. After normalizing with the sample of the total
protein aliquots of the samples were subjected to SDS-
PAGE in a 10 % gel impregnated with 0.1 mg/mL gel-
atin. After electrophoresis, the gels were incubated in
2 % Triton X-100 for 30 min at 37 °C to remove SDS
and in a substrate buffer (50 mM Tris–HCl buffer,
pH 7.8, containing 5 mM CaCl2) for 20 h at 37 °C. Then,
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the gels were stained with Coomassie briliant blue
R250. Gelatinolytic activity was detected as unstained
bands on a blue background. The position of bands
was identified on the basis of the molecular weight
protein standard (BioRad). The cells from passage 7,
9 and 11 were used.
Statistical analysis
All data were analyzed using Statistica software
(version 12). The results were shown as a mean per-
cent value of control ± standard deviation (SD) and
are calculated from at least three independent experi-
ments performed in triplicate; Significant differences
calculated by means of Shaphiro-Wilk and Student-t




In U87MG cell line, control cells showed a different
branchy and polygonal shape, which is considered as the
normal cell growth effect. The most visible changes in
cell morphology were observed after treatment with EEP
and its combination with HPE. The cells were rounded
off, shrunk down and showed a decrease in their number
(Fig. 1).
Cytotoxicity effect of EEP, HPE and their combination
The treatment of U87MG cells with HPE alone
showed a time and dose-dependent decrement in the
cell viability (Fig. 2). The significant inhibitory effect
(viability less than 60 % of control) was found in a
dose 100 μg/ml after 24 h; 50 and 100 μg/ml after
48 h and 25–100 μg/ml after 72 h incubation. After
24, 48 and 72 h of incubation with EEP viability of
U87MG cells decreased to 80.0 ± 11.7 %, 48.9 ± 16.4 %
and 37.3 ± 15.6 %, respectively. The cytotoxic effect of
combination of HPE and EEP extracts on U87MG cells
was significantly higher (p < 0.02) when compared to these
two extracts used separately: after 24 h in concen-
trations of HPE from 6.25 to 100.0 μg/ml, after
48 h in concentrations of HPE from 6.25 to
75.0 μg/ml and after 72 h in concentrations of HPE
from 6.25 to 25.0 μg/ml. Comparing different pe-
riods of incubation, the cytotoxic effect of HPE was
significantly higher (p < 0.05) after 48 h than after
24 h in the concentrations from 3.13 to 100 μg/ml,
while after 72 h it was significantly higher than after
48 h in the concentrations from 25 to 100 μg/ml.
The cytotoxic effect of combination of EEP and
HPE extracts on U87MG cells in different times of
incubation was significantly higher (p < 0.05) after
48 h than 24 h, and after 72 h than 48 h in all used
concentrations.
The influence of EEP, HPE and their combinations on DNA
synthesis
Our study revealed a slight inhibitory potential on DNA
synthesis: 79.2 ± 4.0 % and 89.4 ± 11.8 % of control, re-
spectively, after 48 h of incubation in EEP (30 μg/ml)
and HPE (6.25 μg/ml) used separately (Fig. 3). A statisti-
cally significant inhibitory effect was found for the com-
bination of EEP (30 μg/ml) and HPE (6.25 μg/ml), where
the reduction of DNA synthesis was 43.0 ± 5.8 % of
control.
Mitochondrial potential after treatment with EEP, HPE
and their combinations
The changes of mitochondrial membrane potential in
U87MG cells after incubation with EEP (30 μg/ml), HPE
(6.25 μg/ml) and combination of EEP with HPE were
analyzed with the NucleoCounter NC-3000 instrument.
The results obtained after treatment with combination
of EEP (30 μg/ml) with HPE (6.25 μg/ml) demonstrated
significantly higher (p < 0.05) permeabilization (64.7 ±
3.2 %) compared to the control (6.7 ± 1.5 %) as well as in
comparison with EEP (27.7 ± 9.1 %) and HPE (24.0 ±
6.0 %) used alone (Fig. 4).
Fig. 1 Morphological changes in U87MG cells after treatment with EEP, HPE and their combination. Legend: The effect of ethanolic extract of
propolis (EEP - 30 μg/mL), ethanolic extract of fresh-cut Hypericum perforatum L. (HPE - 6.25 μg/mL) and their combining on morphology of
U87MG cell line after 24 h treatment
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The influence of EEP, HPE and their combinations on
MMP2 and MMP9 secretion
No significant effect of EEP (30 μg/ml) and HPE
(6.25 μg/ml) was revealed on the secretion of pro-
MMP9 and pro-MMP2 (Fig. 5). A significant decrease
(p < 0.05) in pro-MMP9 (8.7 ± 3.7 % of control) and pro-
MMP2 (46.4 ± 16.9 % of control) secretion in U87MG
cells was observed after exposure to combination of EEP
(30 μg/ml) with HPE (6.25 μg/ml).
Cell migration after treatment with EEP, HPE and their
combinations
The effects of EEP (30 μg/ml), HPE (6.25 μg/ml) and
combination of EEP with HPE on cells migration were
evaluated using a scratch-wound assay and the results
were compared to those from cells treated with 0.1 %
DMSO as a control. As shown in Fig. 6, the combination
of EEP with HPE decreased the migration of U87MG
cells after 12 h compared to the control. More open
spaces were observed after 48 h of treatment with com-
bination of EEP with HPE. Moreover, the inhibition of
cell migration by combination of EEP with HPE was
more effective than that of EEP and HPE used alone.
Discussion
The high mortality of patients suffering from glioma, dif-
ficulties in treatment, numerous side effects and failure
of conventional therapy have resulted in search for new
and more efficient substances, also of the natural origin,
as potential anticancer agents. Thus, in this study, the
effect of extract of propolis combined with extract of H.
perforatum L on U87MG glioblastoma cells was exam-
ined via evaluating its anti-proliferative activity.
H. perforatum L. is best known for its use in treatment
of mild to moderate depressive disorders. Its mechanism
of action is unclear. Most researchers confirm that its
effect is related to the return uptake of serotonin at the
neural synapses and the inhibition of monoamine
oxidase (MAO). The most active ingredients of H.
perforatum L. are hypericin and hyperforin. The highest
amount of hypericin (0.115 %) is obtained after ethanolic
extraction, while the best efficiency for hyperforin
(2.397 %) is obtained after supercritical carbon dioxide
extraction [26]. Hypericin is the most widely examined
ingredient of H. perforatum L. Noell et al. [13]
confirmed for the first time that hypericin accumulated
selectively in the implantation of a tumor (C6 glioma) in
rats. The authors suggested that hypericin could be an
effective fluorescence marker for detection of this type
of a tumor. Pfaffel-Schubart et al. [11] showed that the
photosensitizer hypericin strongly inhibited the prolifer-
ation of U373MG glioma cells and induced apoptotic
cell death. It is worth emphasizing that a number of
different compounds present in the H. perforatum L.
extract may interact with individual cell growth mecha-
nisms, showing more evident effects than those used
with each single agent. Roscetti et al. [10] showed that
extract of H. perforatum L. had a significant dose- and
time-dependent inhibition of K562 erythroleukemic cell
Fig. 2 Viability of U87MG cells after treatment with EEP, HPE and
their combination. Legend: Cytotoxicity effect of EEP (30 μg/mL),
HPE (in concentrations 1.56–100.0 μg/mL) and their combinations
after 24 (a), 48 (b) and 72 (c) hours of incubation. The results are
presented as a percentage of control. All statistical analyses were
performed using Student-t test (p < 0.02): *HPE vs HPE with EEP;
#EEP vs HPE with EEP; ● HPE 24 h vs HPE 48 h; ○ HPE 48 h vs HPE
72 h; ■ HPE with EEP 24 h vs HPE with EEP 48 h; □ HPE with EEP
48 h vs HPE with EEP 72 h
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growth and induced apoptosis, while the purified hyperi-
cin had a slight cytotoxic effect on the cell growth and
no effect on the induction of apoptotic cell death. In
another study the extract of H. perforatum L. showed
the phototoxicity effect on human melanoma A375
cancer cells, where IC50 was observed in 78 μg/ml
concentration [27].
In this study, HPE was found to have a time- and
dose-dependent cytotoxic effect on glioblastoma cells,
where this significant inhibitory effect on viability (less
than 60 % of control) was determined in a dose of
50 μg/ml after 48 h of incubation.
Propolis – a natural bee product has been the subject
of many studies due to its anticancer properties. Borges
Fig. 3 [3H]- thymidine incorporation into U87MG cells after treatment with EEP, HPE and EEP with HPE. Legend: 3H]- thymidine incorporation to
U87MG cells after 48 h of incubation with EEP (30 μg/mL), HPE (6.25 μg/mL) and EEP (30 μg/mL) administered together with HPE (6.25 μg/mL).
The results are presented as a percentage of control. Significant changes (p < 0.01): ▲EEP; HPE; EEP with HPE vs Control; *HPE vs HPE with EEP;
#EEP vs HPE with EEP
Fig. 4 Mitochondrial membrane permeabilization in U87MG cells after treatment with EEP, HPE and their combination. Legend: Mitochondrial
membrane permeabilization after treatment (24 h) with EEP (6.25 μg/mL), HPE (30 μg/mL) and combination of EEP (30 μg/mL) with HPE (6.25 μg/mL)
in U87MG cells (a). Data is shown in percentage of permeabilized cells compared to control (b). Significant changes (p < 0.05): ▲EEP; HPE; EEP with
HPE vs Control; *HPE vs HPE with EEP; #EEP vs HPE with EEP
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et al. [28] showed a strong inhibitory effect on the cell
growth on glioblastoma (U251 and U343) and fibroblast
cell lines (MRC5) after treatment with Tubi-bee propolis.
Propolis from Croatia and Brazil showed an antitumor
effect on mammary carcinoma cells (MCA), human
epithelial carcinoma cell line (HeLa) and Chinese
hamster lung fibroblast cells (V79) [29]. In our study, it
was demonstrated that EEP in the concentration of 30 μg/
ml significantly inhibited the growth in U87MG glioma
cells after 24, 48 and 72 h of incubation. Our previous
study revealed the similar effect using propolis obtained
from Poland [23]. The main goal of our research was to
check whether the combination of EEP and HPE would
enhance the antitumor effect or on the contrary - cause
negative interactions and a reverse effect. Our data
showed that the inhibition of U87MG cells growth after
incubation with combination of EEP and HPE was signifi-
cantly higher when compared to these two extracts
Fig. 5 Inhibition of MMPs secretion from U87MG cells after incubation with EEP, HPE and their combination. Legend: Inhibition of MMPs secretion
from U87MG cells after 24 h incubation with EEP (6.25 μg/mL), HPE (30 μg/mL) and combination of EEP (30 μg/mL) with HPE (6.25 μg/mL)
(% of control). The picture is a representative gels of three independent experiments (medium concentrated by 35-fold; 7 μg of protein).
Significant changes (p < 0.05): ▲EEP with HPE vs Control; *HPE vs HPE with EEP; #EEP vs HPE with EEP
Fig. 6 The effects of EEP (6.25 μg/mL), HPE (30 μg/mL) and combination of EEP (30 μg/mL) with HPE (6.25 μg/mL) on U87MG cells migration
after 0, 12, 48 h of incubation
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separately. To the best of our knowledge, this study is the
first to show the cytotoxic effects of H. perforatum L.
combined with propolis on glioblastoma cell line.
In order to confirm that this decreased cells’ viability
was caused by weakening their ability to proliferate, the
EEP and HPE impact on DNA biosynthesis was exam-
ined in a [3H]-thymidine incorporation assay. In our
study, it was determined that the highest inhibition of
proliferation occurred after treatment with combination
of EEP and HPE when compared to these two extracts
applied separately. Aso et al. [30] found that Turkish
propolis showed a potent antitumor activity reflected in
DNA, RNA inhibition and protein synthesis. We
observed disruption of the mitochondrial membrane
potential, which may indicate apoptosis or necrosis in
cells treated with EEP and HPE together [31]. Further
studies are required to verify whether EEP with HPE can
activate apoptotic pathways.
The metastasis process of cancer is strongly connected
with proteolytic enzymes – metalloproteinases (MMPs)
degrading extracellular matrix. MMPs, especially, MMP9
and MMP2 are overexpressed during glioma develop-
ment [32]. Our study results showed that the secretion
of pro-MMP9 and pro-MMP2 from U87MG cells was
significantly decreased after treatment with EEP and
HPE together compared to the control. The significantly
stronger inhibition was observed in comparison with
EEP or HPE used separately. Our previous study with
other bee products proved that beebread and various
honeys also inhibited the secretion of MMP9 and
MMP2 in glioblastoma cells [24, 33]. An integral part of
metastasis that is required at virtually every step of the
metastatic cascade is cell migration [34]. In our study,
inhibition of U87MG cells migration was observed after
treatment with combination of EEP and HPE. These
results confirmed the ability to reduce invasiveness of
glioma cells anti-migration potential of EEP and HPE
combination.
Interestingly, the scientific research on the properties
of active substances of H. perforatum L. has reported ad-
verse drug interactions with other drugs that are metab-
olized by CYP3A4 due to hyperforin content, which
induces CYP3A4 in the gut and liver [35]. Schreiber et
al. [36] described the case of 63 year old woman with
GBM, undergoing contaminant radiochemotherapy with
temozolomide and a slight depressive episode during
which she took H. perforatum L. Five months after
cessation of fractionated radiation and adjuvant
chemotherapy with temozolomide the patient devel-
oped bilateral amaurosis due to radiation-induced
optic neuropathy (RION). The authors suggested that
occurrence of RION may have been the result of radio-
sensitization by temozolomide, which could have been
strengthened by hypericin.
Conclusions
In this study, the combination of ethanolic extract from
propolis and ethanolic extract of fresh-cut H. perforatum
L. was proved the ability to reduce invasiveness of glioma
cells through the inhibition of MMP2 and MMP9
secretion and suppression of cell migration. It has a more
potent anti-proliferative effect on U87MG glioma cell line
compared to using propolis and H. perforatum L. separ-
ately. Further studies are required to verify whether the
examined extracts can activate apoptotic pathways.
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